Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
What I DO….How I BUILD Relationships
Summary
In this episode, Bernadett Mamone shares her educational and professional journey in the medical affairs landscape. She highlights the secrets to becoming a successful MSL, emphasizing the importance of continuous learning and professional development through organizations like HBA, MSL Society, and Toastmasters. Bernadett delves into strategies for developing strong KOL relationships and effective communication, while also addressing the significance of digital engagement. She offers advice on networking, avoiding common MSL mistakes, and maintaining mental clarity. The episode concludes with insights on leveraging additional platforms for professional growth.
My guest today is Bernadett Mamone, PhD, MEd, MSL-BC, Medical Science Liaison at Neurelis, and we discuss her best practices on being a successful MSL and how she builds KOL relationships
Bernadett shares…
👉 What is most important to being a top MSL
👉 Which resources are most valuable as you develop a career as an MSL
👉 Why Toastmasters was a huge help and valuable resource
👉 What some of the key tips are for developing strong relationships with KOLs
👉 Some of the most common mistakes MSLs make
👉 What skills need to be developed for MSLs to achieve success and get to the next level
Medical Science Liaison, KOL relationships, MSL Society, professional development, digital engagement
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary